Skip to content
10-Q

Quarterly Report

INTERNATIONAL STEM CELL CORPORATION ISCO

0000950170-23-041762

← back to feed
Filed
Aug 11, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 8, 2023 8M sh
Current Liabilities Q2 2023 · Jun 30, 2023 $4.74M
Current Liabilities Q2 2023 · Dec 31, 2022 $4.64M
Total Liabilities Q2 2023 · Jun 30, 2023 $5.33M
Total Liabilities Q2 2023 · Dec 31, 2022 $5.36M
Current Assets Q2 2023 · Jun 30, 2023 $3.68M
Current Assets Q2 2023 · Dec 31, 2022 $2.96M
Total Assets Q2 2023 · Jun 30, 2023 $5.79M
Total Assets Q2 2023 · Dec 31, 2022 $5.14M
Shares Diluted restated Q2 2023 · Jun 30, 2022 8M sh
Shares Diluted restated Q2 2023 · Jun 30, 2022 8M sh
Capex Q2 2023 · Jun 30, 2022 $1K
Operating Cash Flow Q2 2023 · Jun 30, 2022 $169K
Stockholders Equity Q2 2023 · Jun 30, 2022 −$4.42M
Stockholders Equity Q2 2023 · Mar 31, 2022 −$4.51M
Stockholders Equity Q2 2023 · Dec 31, 2021 −$4.59M
Sga Expense Q2 2023 · Jun 30, 2022 $872K
Sga Expense Q2 2023 · Jun 30, 2022 $1.7M
Rd Expense Q2 2023 · Jun 30, 2022 $83K
Rd Expense Q2 2023 · Jun 30, 2022 $220K
Net Income Q2 2023 · Jun 30, 2022 −$2K
Net Income Q2 2023 · Jun 30, 2022 −$11K
Net Income Q2 2023 · Mar 31, 2022 −$9K
Operating Income Q2 2023 · Jun 30, 2022 $31K
Operating Income Q2 2023 · Jun 30, 2022 $56K
Cost Of Revenue Q2 2023 · Jun 30, 2022 $718K
Cost Of Revenue Q2 2023 · Jun 30, 2022 $1.44M
Revenue Q2 2023 · Jun 30, 2022 $2.03M
Revenue Q2 2023 · Jun 30, 2022 $4.05M